We observed that the ΔΨm in CD3+ CD19− T cells and CD3− CD19+ B cells was significantly lower in the primary gastrointestinal cancer patients without anti-tumor treatments than that in the healthy donors (Fig. 4A, C and D). Here, CD19 is linked to neoplasm.